Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Harbin Medical UniversityActive in the last 2 years

Dalong Yin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6233-9956; OpenAlex author ID A5074113544. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 3

  1. Metabolism pathway-based subtyping in pancreatic adenocarcinoma: an integrated study by bulk RNA-sequence and machine learning algorithms. Last author DOI 10.1097/js9.0000000000005038↗
  2. Curcumin inhibits the invasion and migration of pancreatic cancer cells by upregulating TFPI-2 to regulate ERK- and JNK-mediated epithelial-mesenchymal transit… Last author DOI 10.1007/s00394-023-03296-5↗
  3. A Novel Oxoglutarate Dehydrogenase-Like Mediated miR-214/TWIST1 Negative Feedback Loop Inhibits Pancreatic Cancer Growth and Metastasis. Co-author DOI 10.1158/1078-0432.ccr-18-4113↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lulu Zhai · 2 shared papers, 2024–2026 · strength 0.64
  2. Hao He · 1 shared paper, 2026 · strength 0.39
  3. Tong-Fa Ju · 1 shared paper, 2024 · strength 0.26
  4. Long-Jiang Chen · 1 shared paper, 2024 · strength 0.26
  5. Wei Wang · 1 shared paper, 2024 · strength 0.26
  6. Dehai Wu · 1 shared paper, 2019 · strength 0.06
  7. Yao Liu · 1 shared paper, 2019 · strength 0.06
  8. Shangha Pan · 1 shared paper, 2019 · strength 0.06
  9. Lianxin Liu · 1 shared paper, 2019 · strength 0.06
  10. Tongsen Zheng · 1 shared paper, 2019 · strength 0.06
  11. Jingxuan Yang · 1 shared paper, 2019 · strength 0.06
  12. Mingyang Liu · 1 shared paper, 2019 · strength 0.06
  13. Min Li · 1 shared paper, 2019 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.